
Unimika 250mg Injection
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Amikacin (250mg)
Overview Unimika 250mg Injection
Cefuroxime 250mg Injection is a broad-spectrum antibiotic combating various bacterial infections. These can affect the urinary system, bones, joints, respiratory system (pneumonia, for example), central nervous system, and bloodstream, among other sites. It's also employed prophylactically in hospitalized individuals. Cefuroxime 250mg Injection inhibits bacterial proliferation. Administered intravenously (IV drip) or intramuscularly by a healthcare professional only, self-injection is strictly prohibited. Adherence to the prescribed dosage schedule is crucial; complete the entire course, even with symptom improvement, to prevent relapse. Premature discontinuation risks infection recurrence or exacerbation. Typical side effects involve injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy warrant immediate medical consultation. High doses may exceptionally cause vertigo, nephrotoxicity, and hearing impairment. Strict adherence to physician instructions is vital, including scheduled monitoring of kidney function, hearing, and urine analysis. Pregnancy contraindicates its use; notify your doctor about pregnancy, pregnancy plans, or breastfeeding.
Uses of Unimika 250mg Injection
Infections caused by bacteria
Major Benefits of Unimika 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Unimika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Unimika 250mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
How Unimika 250mg Injection works:
Unimika 250mg injection is a bacterial growth inhibitor, functioning as an antibiotic by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Unimika 250mg Injection and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Unimika 250mg Injection to pregnant individuals poses a confirmed risk to the fetus, precluding its routine use. In exceptional circumstances involving immediate danger to the mother's life, a physician might exceptionally prescribe it when the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
Administration of Unimika 250mg Injection is considered safe while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Administering Unimika 250mg Injection might cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Refrain from driving if these effects are experienced.
KidneyCAUTION
Exercise caution when administering Unimika 250mg Injection to individuals with impaired renal function. Dosage modification for Unimika 250mg Injection may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Unimika 250mg Injection appears safe for use in individuals with hepatic impairment. Existing evidence indicates dose modification may not be necessary; however, physician consultation is advised.
What if you forget to take Unimika 250mg Injection :
Should you forget a dose of Unimika 250mg Injection, seek medical advice.
Facts to Know About Unimika 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
